Device Trial Radar · NCT03246061
INTRACEPT: Prospective, Randomized, Multi-center Study Intraosseous Basivertebral Nerve Ablation for Treatment of CLBP
Last checked: Nov 20, 2026Latest source record: Apr 2, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
140
Actual
Start
Aug 24, 2017
Primary completion
Jan 18, 2019
Study completion Mar 5, 2024
Sponsor
- Lead sponsor
- Relievant Medsystems, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 11, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 25 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Prospective, open-label, 1:1 randomized controlled trial of Basivertebral nerve (BVN) Ablation arm vs Standard Care Control for the treatment of vertebrogenic chronic low back pain (CLBP). Participants in the the BVN Ablation arm will receive radiofrequency ablation of the BVN using the Intracept procedure for treatment of up to 4 vertebral bodies (L3 to S1). Participants in the Standard Care Control arm will continue on non-surgical standard care and will be offered optional crossover after 12 months of follow-up with follow-up of 6 months post crossover treatment. The study had a pre-specified Interim Analysis with stopping rules for superiority when approximately 60% of the randomized participants have completed their 3-month primary endpoint study visit. An independent Data Safety Management Board (DSMB) reviewed the interim analysis results and recommended stopping enrollments for superiority and offering early crossover to the control arm participants.
Conditions
- Chronic Low Back Pain
Interventions
Intracept SystemDevice
BVN ablation using radiofrequency energy
Standard CareOther
Non-surgical standard care
Primary outcomes
What the sponsor says the trial is designed to measure.
- Difference Between Arms in Least Squared (LS) Mean Change in Oswestry Disability Index (ODI)Time frame: 3 months
Locations
18 sites in 1 country. Site status is shown where the registry gives one.
Alabama Clinical Therapeutics
Birmingham, Alabama
17 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.